← Latest papers
🧬 biology

Symmetry-breaking antibody binding reveals extensive capsid malleability in pandemic human norovirus

This study presents the first atomic cryo-EM structure of the pandemic GII.4 Sydney norovirus capsid, revealing unprecedented malleability where the capsid adopts 11 distinct conformational states to accommodate asymmetric antibody binding, thereby offering critical insights for designing next-generation vaccines.

Original authors: BV Venkataram Prasad, Carmen Apostol, Ramakrishnan Anish, Son Pham, Khalil Ettayebi, Janam Dave, Frederick Neill, Marina Bok, Banumathi Sankaran, Sue Crawford, Robert Atmar, James Crowe, Viviana Parre
Published 2026-09-21
📖 5 min read🧠 Deep dive

Original authors: BV Venkataram Prasad, Carmen Apostol, Ramakrishnan Anish, Son Pham, Khalil Ettayebi, Janam Dave, Frederick Neill, Marina Bok, Banumathi Sankaran, Sue Crawford, Robert Atmar, James Crowe, Viviana Parreño, Mary Estes

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Viruses are not static, hard shells; they are delicate, breathing structures that must balance two opposing needs. To survive outside a host, a virus needs a tough coat to protect its genetic material. But to infect a cell, that same coat must be flexible enough to open up and reveal the tools it uses to enter. This delicate balance, known as plasticity, is a key factor in how viruses evolve and how our immune systems try to stop them. For decades, scientists have known that the immune system fights viruses with antibodies, Y-shaped proteins that latch onto the virus surface like a key in a lock. Usually, researchers study these interactions by freezing the virus and the antibody together and taking a picture, assuming the virus stays in one perfect shape. However, this assumption often misses the reality: when an antibody grabs a virus, the virus might twist, turn, or even break apart to accommodate the intruder. Understanding exactly how a virus bends under this pressure is crucial for designing vaccines that can outsmart these shape-shifting defenses.

Human norovirus is the most common cause of severe stomach flu worldwide, causing millions of cases of vomiting and diarrhea every year. The virus is notorious for its ability to change its appearance just enough to evade the immunity people build up from previous infections. A specific strain, known as GII.4 Sydney, has been the dominant cause of global outbreaks since 2012. To understand why this strain is so successful and how to stop it, a team of researchers at Baylor College of Medicine and other institutions decided to look at the virus in unprecedented detail. They used a powerful imaging technique called cryo-electron microscopy, which allows scientists to see individual virus particles at the atomic level, essentially taking a 3D movie of the virus's structure. Instead of just looking at the virus alone, they mixed it with two different types of antibodies: one that successfully neutralizes the virus and stops it from infecting cells, and another that binds to the virus but does not stop it from causing infection.

The researchers first examined the virus particles on their own. They found that the virus naturally assembles into two different sizes of spherical shells. The smaller, more common shells are made of 180 protein subunits arranged in a specific pattern, while the larger shells contain 240 subunits. In the smaller shells, the virus proteins sit in a flat, resting position. In the larger shells, the proteins are lifted up and twisted, creating a more open, raised shape. Surprisingly, the researchers discovered that the dominant Sydney strain has a unique ability to stay in that flat, resting position without needing help from metal ions or changes in acidity, unlike older strains of the virus. This inherent stability might be one reason why this particular strain has been so successful at spreading globally, as it remains tough and consistent in the environment.

When the team introduced the non-neutralizing antibody, which binds to a hidden part of the virus, the virus did not simply sit still. Instead, it showed a remarkable ability to contort itself. The virus proteins shifted into eleven different shapes to make room for the antibody to attach. In some cases, the proteins lifted up and rotated significantly to expose the hidden target. Even more striking, when the antibody bound to the larger virus shells, it caused those shells to fall apart. The broken pieces did not disappear; instead, they reassembled into much smaller, simpler spheres. These new, smaller particles presented five additional shapes that the virus had never shown before. This demonstrated that the virus is far more malleable than previously thought, capable of completely reorganizing its structure in response to an external threat.

The neutralizing antibody produced a different but equally dramatic effect. When this antibody bound to the virus, it caused the smaller, resting shells to disintegrate completely, leaving only the smaller reassembled particles. The larger shells remained intact but became blurry and unstable, suggesting the antibody was forcing them into a state they could not maintain. The researchers mapped out exactly how the antibody attached to the virus, finding that it could bind in multiple ways, sometimes grabbing one part of the virus and other times grabbing two parts at once. The virus tried to accommodate these different binding patterns by twisting its proteins in various directions, but the sheer number of different shapes it had to adopt eventually destabilized the larger structures.

The study reveals that the pandemic norovirus strain is not a rigid object but a highly adaptable machine. It can shift between resting and raised states, and when attacked by antibodies, it can break apart and rebuild itself into entirely new forms. This extreme flexibility allows the virus to hide its most vulnerable spots from the immune system while still being able to infect cells. The findings suggest that current vaccine strategies, which often rely on the virus staying in one specific shape, might be missing the mark. If the virus can change its shape so easily, a vaccine needs to be designed to lock it into a specific, vulnerable position before it can escape. By understanding the full range of shapes this virus can take, scientists can now work toward creating better vaccines that target the virus when it is most exposed, rather than when it is hiding in its most stable form.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →